Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach

Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1231-1237. Epub 2020 Jun 23.

Abstract

Peripheral neuropathy (PN) has been detected in up to 69% of patients with mixed cryoglobulinaemic syndrome (MCS). PN should be considered in any patient with sensory and/or motor signs and symptoms in the limbs. Electrodiagnostic tests are mandatory for the diagnosis of PN. Several different sets of diagnostic criteria have been created to assess it. All patients suspected of having neuropathy should undergo a nerve conduction study. A complete neurological evaluation at baseline and periodically should be done possibly by the same neurologists. The authors recommend rigorous scientific evidences that may help to obtain superior tools for accurate diagnosis and management of these conditions. Clinicians, armed with experience and recommendations, can find in this review data-driven guidelines to apply treatments of MCS and closely related disorders.

Publication types

  • Review

MeSH terms

  • Cryoglobulinemia* / complications
  • Cryoglobulinemia* / diagnosis
  • Cryoglobulinemia* / therapy
  • Humans
  • Neural Conduction
  • Neurologic Examination
  • Peripheral Nervous System Diseases* / diagnosis
  • Peripheral Nervous System Diseases* / etiology
  • Peripheral Nervous System Diseases* / therapy